ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 88 filers reported holding ABEONA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,000 | -35.3% | 55,000 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $17,000 | -10.5% | 55,000 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $19,000 | -69.4% | 55,000 | 0.0% | 0.01% | -73.7% |
| Q3 2021 | $62,000 | -27.9% | 55,000 | 0.0% | 0.02% | -24.0% |
| Q2 2021 | $86,000 | -16.5% | 55,000 | 0.0% | 0.02% | -30.6% |
| Q1 2021 | $103,000 | +19.8% | 55,000 | 0.0% | 0.04% | +20.0% |
| Q4 2020 | $86,000 | +53.6% | 55,000 | 0.0% | 0.03% | +36.4% |
| Q3 2020 | $56,000 | -65.0% | 55,000 | 0.0% | 0.02% | -69.0% |
| Q2 2020 | $160,000 | +37.9% | 55,000 | 0.0% | 0.07% | +10.9% |
| Q1 2020 | $116,000 | -35.6% | 55,000 | 0.0% | 0.06% | -15.8% |
| Q4 2019 | $180,000 | +45.2% | 55,000 | 0.0% | 0.08% | +38.2% |
| Q3 2019 | $124,000 | -52.9% | 55,000 | 0.0% | 0.06% | -54.5% |
| Q2 2019 | $263,000 | -35.1% | 55,000 | 0.0% | 0.12% | -38.6% |
| Q1 2019 | $405,000 | +3.1% | 55,000 | 0.0% | 0.20% | -17.2% |
| Q4 2018 | $393,000 | – | 55,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 1,359,767 | $3,481,000 | 1.41% |
| DAFNA Capital Management LLC | 181,818 | $465,000 | 0.40% |
| Perceptive Advisors | 1,762,881 | $4,512,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 468,050 | $1,198,000 | 0.26% |
| Soros Fund Management | 1,462,122 | $3,743,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 334,108 | $855,000 | 0.04% |
| KLCM Advisors, Inc. | 28,612 | $73,000 | 0.02% |
| CAMBRIDGE TRUST CO | 65,414 | $167,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 35,400 | $91,000 | 0.01% |
| IFP Advisors, Inc | 10,000 | $74,000 | 0.01% |